SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's earnings have sparked intense debate, with a revenue beat overshadowed by an EPS miss, triggering volatility. The community is focused on the upcoming conference call with Elon Musk, anticipating insights on robotaxis and AI. Broader discussions revolve around Tesla's valuation and future growth prospects in the evolving EV market.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss the implications of the company shipping B1 samples of its QSE-5 cell and active engagements with a new top 10 major OEM. The community is focused on potential partnerships and the company's cash runway extending to 2030 following earnings. Despite some skepticism and debate around valuation, many express confidence in QuantumScape's technology and long-term potential in the battery market.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as investors discuss the recent earnings call, pipeline progress, and cash runway, with some expressing concerns about cash burn while others highlight the potential for partnerships and buyout opportunities. The community is weighing the company's prospects in the competitive GLP-1 market against its financial health and the CEO's strategy. Discussions also involve technical analysis, short positions, and potential catalysts for stock movement.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to its quantum computing breakthrough with HSBC, demonstrating improved bond trading predictions and reinforcing IBM's leadership in the sector; this has sparked significant community discussion around its potential impact and commercial applications with many highlighting the potential for IBM to outperform pure-play quantum stocks. Broader context includes positive sentiment around IBM's strategic focus on AI, hybrid cloud, and consulting services, as well as speculation regarding FAA contract and growing partnerships that are creating a buying opportunity.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending due to a significant earnings miss, sparking concerns about rising medical costs and the impact of Medicaid trends across the healthcare sector. Community members are discussing potential support levels and comparing MOH to competitors like CNC and UNH, while also speculating on potential catalysts like ACA subsidy extensions. The broader context involves uncertainty around government healthcare policy and its effect on managed care organizations.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending as investors discuss the implications of recent study results for its cystic fibrosis treatment, with community analysis focusing on the potential for higher doses to yield better outcomes. Despite some disappointment in initial lung function improvements, there's optimism around mucus reduction data and potential future catalysts like CSL royalties and lawsuit updates. The community speculates on potential buyouts and the company's overall pipeline value.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending as investors react to sector-wide pressures, particularly following Molina's earnings miss, which has sparked concerns about Medicaid margins and dragged down other healthcare stocks. The community is actively debating whether the dip represents a buying opportunity ahead of Centene's upcoming earnings, with some highlighting its undervalued status and potential for a V-shaped recovery contingent upon ACA subsidy extensions and positive earnings.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around OG meme culture and the idea of a 'conviction season.' Advocates emphasize community-driven growth and the resurgence of 2021 vibes, distinguishing themselves from typical coins. The community is actively engaging in spaces and expressing anticipation for potential 'moonshot' opportunities.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is trending due to positive Q3 earnings results that beat expectations, with revenue driven by AI chip production and strong systems revenue growth; however, concerns linger around the impact of tariffs and potential export restrictions, sparking mixed community sentiment regarding future guidance and market conditions; and overall, the stock's movement is influenced by broader trends in the semiconductor equipment sector.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Armata Pharmaceuticals Inc

Armata Pharmaceuticals is trending due to positive Phase 2a clinical trial results for its AP-SA02 bacteriophage cocktail, showing promise in treating Staphylococcus aureus bacteremia; the news is fueling community discussion about the company's potential and small float. Some traders are expressing optimism about the stock's future, while others caution about potential dilution and shorting opportunities. The company's focus on addressing antibiotic-resistant infections is also generating interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medical device company Catheter Precision, Inc. (VTAK) announced on Monday that it has received approval for its suture retention device LockeT in the United Kingdom.LockeT is intended to assist in wound closure after percutaneous venous punctures or procedures involving the insertion of a needle through the skin to access the vein, including for the insertion of catheters. LockeT <a target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=4827478167656712&amp;symbol=VTAK">received</a> CE Mark for European approval and distribution in May 2025, but had to obtain registration to launch sales in the U.K. CE marking indicates a product's compliance with European Union (EU) safety, health, and environmental protection standards, allowing it to be sold freely within the European Economic Area (EEA).On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VTAK">Catheter Precision</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:627/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_at_12_40_56_PM_png_d31ad45d5e.webp" alt="VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits" width="627" height="58"><figcaption>VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they are entering a short position in the stock.<stembedurl>https://stocktwits.com/athebeast/message/625634169</stembedurl>Catheter Precision said it has partnered with HC21, a U.K.-based distributor, to distribute LockeT. Fatih Ayoglu, Sales Manager EMEA and APAC, said that the device’s intuitive design and ease of deployment enable earlier discharge following cardiac procedures.“This directly supports NHS efforts to reduce waiting lists by freeing up hospital capacity and accelerating patient throughput. With the NHS recently achieving its first reduction in waiting lists in 17 years, LockeT is poised to contribute meaningfully to this momentum by helping clinicians deliver more treatments, more efficiently,” Ayoglu added.VTAK stock is down by 56% this year and by about 91% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/vanda-pharma-stock-rallies-after-federal-appeals-court-sets-aside-fda-action/chsOi7vRdXQ">Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did Catheter Precision Stock Soar 49% Today?

The company’s product LockeT, which bagged approval in the U.K., had received CE Mark for European approval and distribution in May 2025.

Equity

The company’s product LockeT, which bagged approval in the U.K., had received CE Mark for European approval and distribution in May 2025.


Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins on September 4, 2002 and is headquartered in Fort Mill, SC.

VTAK
Catheter Precision Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VTAK News

VTAKCatheter Precision Inc.